CHU Nancy
Vandœuvre-lès-Nancy, 54511, France
Location status: Recruiting
NCT Number: NCT03309384
The goal of this study is to evaluate the role of intraoperative continous and intermittent neuromonitoring and intraoperative parathormone (PTH) to predict postoperative nerve morbidity and hypocalcemia.
Interested in participating?
Request InfoAll sexes
Observational
Vandœuvre-lès-Nancy, 54511, France
Location status: Recruiting
Intraoperative PTH values and intraoperative continuous neuromonitoring will be collected prospectively in consecutive patients who undergo total thyroidectomy.
Postoperative parathyroid morbidity and recurrent laryngeal nerve morbidity will be evaluated within 1 week after total thyroidectomy and at 1 year postoperatively.
Other postoperative morbidity will be evaluated at 1 year postoperatively using validated classification.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: intraoperative
parathormone in pg/mL
Time frame: within 1 week after thyroidectomy
calcium in mg/L
Time frame: within 1 week after thyroidectomy
parathormone in pg/mL
Time frame: at one year after thyroidectomy
calcium in mg/L
Time frame: at one year after thyroidectomy
parathormone in pg/mL
Time frame: during thyroidectomy
continuous intraoperative neuromonitoring (> 50% baseline values yes/no)
Time frame: within 1 week after thyroidectomy
laryngoscopy (normal / palsy)
Time frame: at one year after thyroidectomy
laryngoscopy (normal / palsy)
Time frame: at one year after thyroidectomy
Postoperative morbidity classification (using a Clavien-Dindo classification) postoperatively
Contact information is provided by the study sponsor or research team.
Central Hospital, Nancy, France
Other
Intraoperative Monitoring (Parathormone Values and Continuous Neuromonitoring) to Predict Postoperative Complications After Total Thyroidectomy
Acronym: PARACAL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03910049
Endocrine System Diseases, Hypoparathyroidism
Thessaloniki, Please Enter the State Or Province, Greece
View Trial DetailsNCT04571736
Endocrine System Diseases, Thyroid
Montpellier, Hérault, France
View Trial DetailsNCT05733013
Endocrine Gland Neoplasms, Endocrine System Diseases
New York, United States
View Trial DetailsNCT04615988
Avitaminosis, Cancer
New York, United States
View Trial Details